RENAL FUNCTION DIFFERENCE BETWEEN ANTI-HEPATITIS B IMMUNOGLOBULIN (HBIG) MONOTHERAPY AND HBIG COMBINED WITH ENTECAVIR

被引：0
|
作者：
Lee, Jae Geun [1 ]
Ju, Man Ki [1 ]
Choi, Sub Jin [1 ]
Kim, Soon Il [1 ]
Kim, Myoung Soo [1 ]
Joo, Dong Jin [1 ]
Lee, Juhan [1 ]
Song, Seung Hwan [1 ]
机构：
[1] Yonsei Univ, Seoul 120749, South Korea
来源：
TRANSPLANT INTERNATIONAL | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
P624
引用
收藏
页码：707 / 707
页数：1
相关论文
共 50 条
  • [21] Prophylactic hepatitis B immunoglobulin (HBIg) in liver transplant (OLT) recipients: Anti-HBs titers on a fixed dosing schedule
    Terrault, NA
    Hahn, JA
    Lake, JR
    Roberts, JP
    Ascher, NL
    Wright, TL
    GASTROENTEROLOGY, 1996, 110 (04) : A1344 - A1344
  • [22] Combination HBIG and lamivudine is both highly efficacious and cost-effective in preventing recurrent hepatitis B in orthotopic liver transplant recipients compared to HBIG monotherapy.
    Han, SHB
    Martin, P
    Ofman, J
    Holt, C
    Drazan, K
    Artinian, L
    Kunder, G
    Farmer, D
    Ghobrial, RM
    Busuttil, RW
    HEPATOLOGY, 1999, 30 (04) : 242A - 242A
  • [23] Combination prophylaxis with lamivudine (LAM) and hepatitis B immunoglobulin (HBIG) prevents graft re-infection by hepatitis B (HBV)
    Lai, V
    Elias, E
    O'Donnell, K
    Mutimer, D
    GUT, 2002, 50 : A115 - A115
  • [24] Renal Tubular Dysfunction of Prophylactic Treatment With Anti-Hepatitis B Immunoglobulin Combined Lamivudine and Adefovir Dipivoxil in Liver Recipients
    Lee, Jae Geun
    Lee, Juhan
    Lee, Jung Jun
    Ju, Man Ki
    Choi, Gi Hong
    Kim, Myoung Soo
    Choi, Jin Sub
    Kim, Soon Il
    Joo, Dong Jin
    TRANSPLANTATION, 2015, 99 : 272 - 272
  • [25] Reduced Hepatitis B Immunoglobulin (HBIg) Role in the Era of Potent Nucleos(t)ide Analogues for Hepatitis B Virus (HBV) Prophylaxis
    Singer, George
    Zielsdorf, Shannon
    Fleetwood, Vidyaratna
    Eswaran, Sheila
    Cohen, Eric
    Alvey, Nicole
    Chan, Edie
    Shah, Nikunj
    Fayek, Sameh
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 100 - 100
  • [26] Dual effects of hepatitis B (HBV) infection and hepatitis B immunoglobulin (HBIg) in reducing the incidence of acute rejection post-transplantation.
    Pessoa, MG
    Kim, E
    Martin, P
    Crippin, J
    Keeffe, E
    Gish, R
    Ascher, N
    Wright, TL
    Terrault, NA
    GASTROENTEROLOGY, 1998, 114 (04) : A1322 - A1322
  • [27] EFFICACY OF HEPATITIS-B IMMUNOGLOBULIN (HBIG) IN PREVENTION OF HEPATITIS-B - 2-YEAR FOLLOW-UP-STUDY
    FARZADEGAN, H
    SHAMSZAD, M
    ALA, F
    GASTROENTEROLOGY, 1979, 76 (05) : 1130 - 1130
  • [28] Hepatitis B virus surface gene mutations are often associated with lamivudine resistance mutations in the absence of treatment with hepatitis B immunoglobulin (HBIG)
    Barnes, E
    Mathou, N
    Qattan, I
    Brown, D
    Bloor, S
    Clarke, B
    Dhillon, A
    Dusheiko, G
    GUT, 2003, 52 (05)
  • [29] A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation
    Buti, M
    Mas, A
    Prieto, M
    Casafont, F
    Gonzalez, A
    Miras, M
    Herrero, JI
    Jardí, R
    de Castro, EC
    García-Rey, C
    JOURNAL OF HEPATOLOGY, 2003, 38 (06) : 811 - 817
  • [30] Living Related Liver Transplant (LRLT) in HBV Related Liver Disease without Hepatitis B Immunoglobulin (HBIG).
    Wadhawan, Manav
    Gupta, Subash
    Goyal, Neerav
    Taneja, Sunil
    LIVER TRANSPLANTATION, 2013, 19 : S91 - S92
12345